101 related articles for article (PubMed ID: 19187428)
1. Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs.
Rollman E; Mason RD; Lin J; Brooks AG; Kent SJ
J Med Primatol; 2008 Dec; 37 Suppl 2():24-32. PubMed ID: 19187428
[TBL] [Abstract][Full Text] [Related]
2. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
3. Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.
Rollman E; Smith MZ; Brooks AG; Purcell DF; Zuber B; Ramshaw IA; Kent SJ
J Immunol; 2007 Oct; 179(7):4571-9. PubMed ID: 17878354
[TBL] [Abstract][Full Text] [Related]
4. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ
J Virol; 2013 Apr; 87(8):4146-60. PubMed ID: 23345519
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6.
Miller CJ; Abel K
J Med Primatol; 2005 Oct; 34(5-6):271-81. PubMed ID: 16128922
[TBL] [Abstract][Full Text] [Related]
7. Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8
Hodara VL; Parodi LM; Keckler MS; Giavedoni LD
AIDS Res Hum Retroviruses; 2016; 32(10-11):1125-1134. PubMed ID: 26986800
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques.
Kent SJ; De Rose R; Mokhonov VV; Mokhonova EI; Fernandez CS; Alcantara S; Rollman E; Mason RD; Loh L; Peut V; Reece JC; Wang XJ; Wilson KM; Suhrbier A; Khromykh A
Virology; 2008 May; 374(2):528-34. PubMed ID: 18272194
[TBL] [Abstract][Full Text] [Related]
9. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
10. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
Sharpe SA; Cope A; Dowall S; Berry N; Ham C; Heeney JL; Hopkins D; Easterbrook L; Dennis M; Almond N; Cranage M
J Gen Virol; 2004 Sep; 85(Pt 9):2591-2602. PubMed ID: 15302953
[TBL] [Abstract][Full Text] [Related]
11. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
Mason RD; De Rose R; Kent SJ
Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
[TBL] [Abstract][Full Text] [Related]
12. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
Peut V; Kent SJ
Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.
Calarota SA; Hokey DA; Dai A; Jure-Kunkel MN; Balimane P; Weiner DB
Vaccine; 2008 Jun; 26(25):3121-34. PubMed ID: 18336959
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity in experimental SIV infection and vaccination.
Ahmed RK; Biberfeld G; Thorstensson R
Mol Immunol; 2005 Feb; 42(2):251-8. PubMed ID: 15488612
[TBL] [Abstract][Full Text] [Related]
16. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
[TBL] [Abstract][Full Text] [Related]
17. Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques.
Mason RD; Rose RD; Seddiki N; Kelleher AD; Kent SJ
Virology; 2008 Nov; 381(1):11-5. PubMed ID: 18835006
[TBL] [Abstract][Full Text] [Related]
18. What's the matter with HIV-directed killer T cells?
Wick D; Self SG
J Theor Biol; 2002 Nov; 219(1):19-31. PubMed ID: 12392972
[TBL] [Abstract][Full Text] [Related]
19. [Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models].
Fukazawa Y
Uirusu; 2012; 62(2):167-74. PubMed ID: 24153227
[TBL] [Abstract][Full Text] [Related]
20. Immunity in natural SIV infections.
Silvestri G
J Intern Med; 2009 Jan; 265(1):97-109. PubMed ID: 19093963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
